[go: up one dir, main page]

AU2000258901A1 - Treatment of skin damage using olive oil polyphenols - Google Patents

Treatment of skin damage using olive oil polyphenols

Info

Publication number
AU2000258901A1
AU2000258901A1 AU2000258901A AU5890100A AU2000258901A1 AU 2000258901 A1 AU2000258901 A1 AU 2000258901A1 AU 2000258901 A AU2000258901 A AU 2000258901A AU 5890100 A AU5890100 A AU 5890100A AU 2000258901 A1 AU2000258901 A1 AU 2000258901A1
Authority
AU
Australia
Prior art keywords
treatment
olive oil
skin damage
oil polyphenols
polyphenols
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000258901A
Inventor
Nicholas V. Perricone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2000258901A1 publication Critical patent/AU2000258901A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2000258901A 2000-04-06 2000-06-23 Treatment of skin damage using olive oil polyphenols Abandoned AU2000258901A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19517100P 2000-04-06 2000-04-06
US60195171 2000-04-06
PCT/US2000/017488 WO2001076579A1 (en) 2000-04-06 2000-06-23 Treatment of skin damage using olive oil polyphenols

Publications (1)

Publication Number Publication Date
AU2000258901A1 true AU2000258901A1 (en) 2001-10-23

Family

ID=22720304

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000258901A Abandoned AU2000258901A1 (en) 2000-04-06 2000-06-23 Treatment of skin damage using olive oil polyphenols

Country Status (3)

Country Link
US (1) US6437004B1 (en)
AU (1) AU2000258901A1 (en)
WO (1) WO2001076579A1 (en)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775976B1 (en) * 1998-03-10 2000-06-02 Fabre Pierre Dermo Cosmetique PHARMACEUTICAL OR COSMETIC COMPOSITION CONTAINING AN ACTIVE PRECURSOR HYDROLYSABLE BY GLUCOCEREBROSIDASE
FR2808191B1 (en) * 2000-04-28 2004-03-05 Oreal PLANT EXTRACT OF THE SPECIES OLEA EUROPAEA AS NO-SYNTHASE INHIBITOR AND USES
CA2406570C (en) * 2000-05-09 2011-07-12 Kaneka Corporation Dermal compositions containing coenzyme q as the active ingredient
US7713569B2 (en) * 2000-09-01 2010-05-11 Creagri, Inc. Hydroxytyrosol-rich composition from olive vegetation water and method of use thereof
PT1315691E (en) 2000-09-01 2012-11-22 Creagri Inc METHOD FOR OBTAINING A RICH COMPOSITION IN HYDROXYTANOLSOL FROM VEGETATION WATER
US20030206965A1 (en) * 2000-09-29 2003-11-06 The Procter & Gamble Company Allergen neutralization compositions
BR0209922A (en) * 2001-05-23 2004-07-27 Hamdi K Hamdi Method for treating a medical condition involving angiogenesis in a patient, inhibiting endothelial cell vascularization, and treating cancer in a mammal
FR2825022B1 (en) * 2001-05-23 2005-01-14 Seppic Sa COMPOSITION OF OLIVE POLYPHENOLS. USE AS A COSMETIC AND DIETETIC ACTIVE
AU2003211118A1 (en) 2002-02-13 2003-09-04 Creagri, Inc. Method and composition for treatment of inflammation and aids-associated neurological disorders
ES2193874B1 (en) * 2002-04-03 2005-03-01 Puleva Biotech, S.A. NATURAL AND DERIVATIVE COMPOUNDS OF THESE FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR, HEPATIC, RENAL AND COSMETIC DISEASES.
US7468355B2 (en) * 2002-05-22 2008-12-23 H2Rc Corporation Methods for inhibiting cancer and scar formation
EP1558199A4 (en) * 2002-10-11 2006-06-28 Creagri Inc THERAPEUTIC COMBINATION OF CARNITINE AND ANTIOXIDANT POLYPHENOLS
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20160158261A1 (en) * 2002-10-25 2016-06-09 Foamix Pharmaceuticals Ltd. Antibiotic Kit and Composition and Uses Thereof
FR2853549B1 (en) * 2003-04-11 2007-11-09 Agronomique Inst Nat Rech NUTRITIONAL OR THERAPEUTIC COMPOSITION CONTAINING THE OLEUROPE COMPOUND OR ONE OF ITS DERIVATIVES
KR20050007883A (en) * 2003-07-12 2005-01-21 (주)현덕비엔티 Composition for anti-phototoxic effect on skin comprising polyphenol purified from green tea, and ascorbic acid and its derivatives
US7205011B2 (en) * 2003-11-14 2007-04-17 Board Of Regents, Acting For And On Behalf Of, University Of Arizona Anti-inflammatory activity of a specific turmeric extract
FR2864785B1 (en) * 2004-01-06 2006-02-10 Oreal COSMETIC COMPOSITION COMPRISING AN EXTRACT OF OLIVE SHEET AND A VEGETATION EXTRACT FROM OLIVES
US20080234225A1 (en) * 2004-03-15 2008-09-25 John Lezdey Method of treatment
KR100868905B1 (en) * 2004-03-26 2008-11-14 (주)아모레퍼시픽 Composition for preventing skin damage induced by ultraviolet irradiation containing ginsenoside F1 and EVCＧ
JP2008509224A (en) * 2004-08-09 2008-03-27 クレアグリ， インコーポレイテッド Olive compositions and methods for treating inflammatory conditions
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
EP1802258A4 (en) 2004-09-13 2015-09-23 Chrono Therapeutics Inc Biosynchronous transdermal drug delivery
MX2007003126A (en) 2004-09-14 2007-08-02 Ajinomoto Omnichem S A Topical compositions containing phosphorylated polyphenols.
US20070042026A1 (en) * 2005-03-17 2007-02-22 Wille John J Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions
US7252834B2 (en) * 2005-04-25 2007-08-07 Clemson University Research Foundation (Curf) Elastin stabilization of connective tissue
US8372040B2 (en) 2005-05-24 2013-02-12 Chrono Therapeutics, Inc. Portable drug delivery device including a detachable and replaceable administration or dosing element
US9789149B2 (en) * 2005-07-19 2017-10-17 Creagri, Inc. Vegetation water composition for treatment of inflammatory skin conditions
ES2291111B1 (en) * 2006-02-17 2009-03-16 Universidad De Granada PROCEDURE FOR THE INDUSTRIAL USE OF TIROSOL AND HYDROXYTIROSOL CONTAINED IN THE SOLID SUBPRODUCTS OF THE INDUSTRIAL MOLTURATION OF THE OLIVE.
US8841264B2 (en) * 2006-07-14 2014-09-23 Dsm Ip Assets B.V. Compositions
EP2049134A2 (en) * 2006-07-14 2009-04-22 DSMIP Assets B.V. Compositions comprising rosehip and other active agents for the treatment of inflammatory disorders
WO2008006582A1 (en) * 2006-07-14 2008-01-17 Dsm Ip Assets B.V. Compositions comprising magnolol or honokiol and other active agents for the treatment of inflammatory diseases
FR2912055B1 (en) * 2007-02-06 2009-05-15 Idenov Lab COSMETIC COMPOSITION COMPRISING ANTI-INFLAMMATORY, REPAIRING, SOOTHING AND MOISTURIZING ACTIVE INGREDIENTS FOR CALMING SKIN IRRITATION
EP1982707A1 (en) * 2007-04-18 2008-10-22 DSMIP Assets B.V. Use of hydroxytyrosol as anti-aging agent
US8617544B2 (en) * 2007-05-01 2013-12-31 Richard L. Kozlenko Compositions and methods for controlling lipid metabolism
FR2918278B1 (en) * 2007-07-04 2009-11-20 Girex USE OF OLEOCANTHAL IN THE TREATMENT OF SKIN INFLAMMATION.
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090155337A1 (en) * 2007-11-12 2009-06-18 Endologix, Inc. Method and agent for in-situ stabilization of vascular tissue
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
EP2257274A4 (en) * 2008-02-21 2011-07-20 Vatrix Medical Inc Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle
US8071139B2 (en) * 2008-09-04 2011-12-06 Alan David Widgerow Treatment of damaged skin
US8591961B2 (en) 2008-09-04 2013-11-26 Allergan, Inc. Aesthetic treatment of scars and aging skin
US20100016833A1 (en) * 2008-07-15 2010-01-21 Ogle Matthew F Devices for the Treatment of Vascular Aneurysm
US20100119605A1 (en) * 2008-11-12 2010-05-13 Isenburg Jason C Compositions for tissue stabilization
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2010151778A2 (en) * 2009-06-25 2010-12-29 Darlene Mccord Topical compositions and methods for wound care
US8796315B2 (en) 2009-06-25 2014-08-05 Darlene E. McCord Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US8496911B2 (en) * 2009-07-29 2013-07-30 Vatrix CHF, Inc. Tissue stabilization for heart failure
WO2011019735A2 (en) 2009-08-10 2011-02-17 Darlene Mccord Nutritional supplements
JP2013527126A (en) * 2009-09-22 2013-06-27 ユニバーシティ・オブ・ケープ・タウン Hydroxytyrosol compound
WO2011064631A1 (en) 2009-10-02 2011-06-03 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
WO2011044455A1 (en) * 2009-10-09 2011-04-14 Vatrix Medical, Inc. In vivo chemical stabilization of vulnerable plaque
US8444624B2 (en) * 2009-10-19 2013-05-21 Vatrix Medical, Inc. Vascular medical devices with sealing elements and procedures for the treatment of isolated vessel sections
US8580742B2 (en) 2010-03-05 2013-11-12 N.V. Perricone Llc Topical glutathione formulations for menopausal skin
US8609604B2 (en) 2009-12-28 2013-12-17 N.V. Perricone Llc Methods of improving the appearance of aging skin
WO2011081716A1 (en) 2009-12-28 2011-07-07 N.V. Perricone Llc Topical acyl glutathione formulations
US20110160144A1 (en) * 2009-12-28 2011-06-30 Perricone Nicholas V Topical Acyl Glutathione Formulations
US20110245182A1 (en) 2010-04-06 2011-10-06 Perricone Nicholas V Topical Uses of Szeto-Schiller Peptides
US20110245183A1 (en) 2010-04-06 2011-10-06 Perricone Nicholas V Topical Uses of Szeto-Schiller Peptides
US20120083452A1 (en) 2010-09-30 2012-04-05 Perricone Nicholas V Topical Anesthetic Uses of Szeto-Schiller Peptides
US8414869B2 (en) 2010-11-30 2013-04-09 N.V. Perricone Llc Melanin promoting topical composition
US8911468B2 (en) 2011-01-31 2014-12-16 Vatrix Medical, Inc. Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection
US8609618B2 (en) 2011-03-25 2013-12-17 N.V. Perricone Llc Topical palmitoyl glutathione formulations
US9937255B2 (en) 2011-05-18 2018-04-10 Nectero Medical, Inc. Coated balloons for blood vessel stabilization
WO2013006643A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
US9283241B2 (en) 2012-07-10 2016-03-15 Clemson University Treatment to render implants resistant to diabetes
EP2925307B1 (en) 2012-11-30 2020-10-28 McCord, Darlene E. Hydroxytyrosol and oleuropein compositions for induction of dna damage, cell death and lsd1 inhibition
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
WO2014150174A1 (en) * 2013-03-15 2014-09-25 Mccord Darlene E Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells
EP3384906A1 (en) 2013-12-23 2018-10-10 Medical Brands Research B.V. Dermatological composition based on algae and olive leaf extracts
CN103893237B (en) * 2014-04-14 2016-08-17 成都一平医药科技发展有限公司 A kind of containing Cornu Cervi Pantotrichum with the compositions of Fructus Canarii albi extract
US10213586B2 (en) 2015-01-28 2019-02-26 Chrono Therapeutics Inc. Drug delivery methods and systems
AU2016228779A1 (en) 2015-03-12 2017-09-07 Chrono Therapeutics Inc. Craving input and support system
MX377365B (en) 2016-09-08 2025-03-10 Journey Medical Corp COMPOSITIONS AND METHODS FOR TREATING ROSACEA AND ACNE.
KR101839109B1 (en) * 2016-09-22 2018-03-15 ㈜프론트바이오 Composition for preventing or treating skin disease, comprising extract of purple corn
WO2018129304A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
WO2019232077A1 (en) 2018-05-29 2019-12-05 Chrono Therapeutics Inc. Drug delivery methods and systems
CA3119992A1 (en) 2018-11-16 2020-05-22 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system
CN111904955A (en) * 2020-08-26 2020-11-10 佛山市康伲爱伦生物技术有限公司 Hydroxytyrosol and its derivatives for relieving xeroderma and application thereof
KR20230069232A (en) * 2020-09-23 2023-05-18 바넷 프로덕츠 엘엘씨 Synergistic antioxidant cosmetic composition containing at least one hydroxytyrosol and at least one sulforaphane
US12414960B2 (en) 2020-10-13 2025-09-16 Attica Sciences Ltd. Analogues of oleuropein and oleacein and uses thereof
IT202200009722A1 (en) * 2022-05-11 2023-11-11 Active Italia S R L “Preparation based on olive oil polyphenols in eutectic solvents and their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2652086B1 (en) 1989-09-20 1993-05-21 Andary Claude NEW COMPOSITION OF PLANT ORIGIN, DERIVATIVE OF CAFEIC ACID, ORAPOSIDE; COMPOSITION FOR THERAPEUTIC USE AND DERMATO-COSMETIC COMPOSITION CONTAINING THE SAME.
EP0576420B1 (en) 1991-03-21 1995-05-31 Parfums Christian Dior Novel derivative of caffeic acid, oraposide, cosmetic or pharmaceutical, particularly dermatological, composition containing it
JP3499616B2 (en) * 1994-10-20 2004-02-23 一丸ファルコス株式会社 Application to hydroxytyrosol, melanin production inhibitor or lipid peroxide production inhibitor
JPH08151319A (en) 1994-11-25 1996-06-11 T Hasegawa Co Ltd Ultraviolet absorber and external preparation for skin containing the same
WO1999052377A1 (en) * 1998-04-14 1999-10-21 Unilever N.V. Fortification of a vegetable fat with antioxidants

Also Published As

Publication number Publication date
US6437004B1 (en) 2002-08-20
WO2001076579A1 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
AU2000258901A1 (en) Treatment of skin damage using olive oil polyphenols
AU2000260550A1 (en) Treatment of skin damage using polyenylphosphatidylcholine
GB0025639D0 (en) Cosmetic treatment of skin conditions
AUPQ877300A0 (en) Topical treatment of skin
AU2002229644A1 (en) Cosmetic compositions for preventing skin irritation
AU2001240046A1 (en) Method of treating skin conditions
AU2002242904A1 (en) Skin treatment comprising alcohol spirit
AU2002220679A1 (en) Cosmetic method of treating skin
AU2002319286A1 (en) Skin treatment
AU2001283850A1 (en) Method for protecting human skin
GB2360453B (en) Treatment of skin conditions
AU2002220694A1 (en) Cosmetic method of treating skin
GB0101146D0 (en) Treatment of skin conditions
IL154011A0 (en) Treatment of wounds
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2001272195A1 (en) Topical treatment of skin
AUPQ525600A0 (en) Laser treatment of skin conditions
AU2291102A (en) Compositions and methods for the treatment of skin damage
AUPQ811200A0 (en) Treatment of alopecia
EP1284748A4 (en) Treatment of damaged connective tissue
GB0023071D0 (en) Treatment of inflammatory skin conditions
AU2001250000A1 (en) Treatment of vitiligo
GB9914106D0 (en) Treatment of oils
GB9914103D0 (en) Treatment of oils
GB9914101D0 (en) Treatment of oils